Stay updated on Pembrolizumab for Biliary Tract Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Biliary Tract Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Biliary Tract Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Revision: v3.5.2 has been added and v3.5.0 has been removed. This is a minor maintenance update that does not affect study details or user-facing content.
    Difference
    0.1%
    Check dated 2026-04-16T10:51:30.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    40 days ago
    Change Detected
    Summary
    Revision history updated: added v3.5.0 and removed v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-18T17:49:40.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T14:41:23.000Z thumbnail image
  6. Check
    76 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2. Removed the funding-status notice and the previous Revision: v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-11T01:17:14.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Added a government funding lapse notice banner. Updated the site revision from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T00:24:18.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    The changes add a glossary display toggle and update page metadata by introducing 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0', while removing the older labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-27T23:46:07.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Biliary Tract Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Biliary Tract Cancer Clinical Trial page.